Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response Variability in Children With ADHD
NCT01238822Phase 4Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jun 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (4 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: ADHD Total Sum Score of All 18 ADHD Symptom Items at 4 weeks. Started Jun 2006; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01238822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01238822.